anti-Chemokine (C-C Motif) Ligand 20 (CCL20) Antikörper

chemokine upregulated in ischemic brain tissue [RGD, Feb 2006].. Zusätzlich bieten wir Ihnen CCL20 Kits (114) und CCL20 Proteine (80) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
CCL20 6364 P78556
CCL20 20297 O89093
CCL20 29538 P97884
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-CCL20 Antikörper auf antikoerper-online.de

Showing 10 out of 218 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Anbieter Lieferzeit Preis Details
Hund Kaninchen Unkonjugiert WB WB Suggested Anti-Ccl20 Antibody Titration:  0.2-1 ug/ml  ELISA Titer:  1:62500  Positive Control:  Rat Heart 100 μL Anmelden zum Anzeigen 2 bis 3 Tage
$289.00
Details
Human Ziege Unkonjugiert ELISA, IHC   100 μg Anmelden zum Anzeigen 6 bis 7 Tage
$429.84
Details
Human Maus FITC FACS, IHC (f), IHC (p), IP Surface staining of human peripheral blood leukocytes by mouse monoclonal anti-CD45R0 antibody UCHL1 . 100 Tests Anmelden zum Anzeigen 5 bis 7 Tage
$428.84
Details
Human Maus APC FACS, IHC (f), IHC (p), IP Surface staining of human peripheral blood leukocytes by mouse monoclonal anti-CD45R0 antibody UCHL1 . 100 Tests Anmelden zum Anzeigen 5 bis 7 Tage
$497.45
Details
Human Maus PE FACS, IHC (f), IHC (p), IP Surface staining of human peripheral blood leukocytes by mouse monoclonal anti-CD45R0 antibody UCHL1 . 100 Tests Anmelden zum Anzeigen 5 bis 7 Tage
$497.45
Details
Human Maus Unkonjugiert FACS, IHC (f), IHC (p), IP Surface staining of human peripheral blood leukocytes by mouse monoclonal anti-CD45R0 antibody UCHL1 . 0.1 mg Anmelden zum Anzeigen 5 bis 7 Tage
$411.68
Details
Maus Ratte Biotin WB Western Blot of Mouse MIP 3α (RAT) antibody Lane 1: mouse recombinant MIP-3a Lane 2: human recombinant MIP-3a Primary antibody: MIP 3α antibody at 0.1 ug/ml for overnight at 4°C Secondary antibody: goat anti-rat at 1:10,000 for 45 min at RT Block: 5% BLOTTO overnight at 4°C 100 μg Anmelden zum Anzeigen 5 bis 7 Tage
$598.50
Details
Maus Kaninchen Unkonjugiert WB Western blot analysis of MIP-3 Alpha/CCL20 using anti-MIP-3 Alpha/CCL20 antibody . Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each  Lane was loaded with 50ug of sample under reducing conditions.  Lane 1: rat testis tissue lysates, Lane 2: mouse testis tissue lysates. After Electrophoresis, proteins were transferred to a Nitrocellulose membrane at 150mA for 50-90 minutes. Blocked the membrane with 5% Non-fat Milk/ TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-MIP-3 Alpha/CCL20 antigen affinity purified polyclonal antibody (Catalog # ) at 0.5 ug/mL overnight at 4℃, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:10000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for MIP-3 Alpha/CCL20 at approximately 14KD. The expected band size for MIP-3 Alpha/CCL20 is at 14KD. 100 μg Anmelden zum Anzeigen 4 bis 6 Tage
$240.00
Details
Human Maus Biotin WB Western Blot of Human MIP 3α (Mouse) Antibody Lane 1: human recombinant MIP-3a Lane 2: mouse recombinant MIP-3a Primary antibody: Human MIP 3α (RAT) Antibody at 0.5 ug/ml for overnight at 4°C Secondary antibody: goat anti-rabbit at 1:10,000 for 45 min at RT Block: 5% BLOTTO overnight at 4°C 100 μg Anmelden zum Anzeigen 5 bis 7 Tage
$598.50
Details
Maus Ratte Unkonjugiert WB Western Blot of Mouse MIP 3α (RAT) antibody Lane 1: mouse recombinant MIP-3a Lane 2: human recombinant MIP-3a Primary antibody: MIP 3α antibody at 0.1 ug/ml for overnight at 4°C Secondary antibody: goat anti-rat at 1:10,000 for 45 min at RT Block: 5% BLOTTO overnight at 4°C 100 μg Anmelden zum Anzeigen 5 bis 7 Tage
$598.50
Details

Am meisten referenzierte anti-CCL20 Antikörper

  1. Human Monoclonal CCL20 Primary Antibody für FACS, IHC (f) - ABIN192399 : Dawes, Petrova, Liu, Wraith, Beverley, Tchilian: Combinations of CD45 isoforms are crucial for immune function and disease. in Journal of immunology (Baltimore, Md. : 1950) 2006 (PubMed)
    Show all 9 Pubmed References

  2. Human Monoclonal CCL20 Primary Antibody für FACS, IHC (f) - ABIN192398 : Cosenza-Nashat, Kim, Zhao, Suh, Lee: CD45 isoform expression in microglia and inflammatory cells in HIV-1 encephalitis. in Brain pathology (Zurich, Switzerland) 2006 (PubMed)
    Show all 9 Pubmed References

  3. Human Monoclonal CCL20 Primary Antibody für FACS, IHC (f) - ABIN192395 : Li, Tsuyama, Ishikawa, Obata, Abroun, Liu, Otsuyama, Zheng, Ma, Maki, Kawano: A rapid translocation of CD45RO but not CD45RA to lipid rafts in IL-6-induced proliferation in myeloma. in Blood 2005 (PubMed)
    Show all 8 Pubmed References

  4. Human Monoclonal CCL20 Primary Antibody für FACS, IHC (f) - ABIN192397 : Akbar, Terry, Timms, Beverley, Janossy: Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. in Journal of immunology (Baltimore, Md. : 1950) 1988 (PubMed)
    Show all 9 Pubmed References

  5. Human Monoclonal CCL20 Primary Antibody für IHC (p) - ABIN786800 : Cassier, Treilleux, Bachelot, Ray-Coquard, Bendriss-Vermare, Ménétrier-Caux, Trédan, Goddard-Léon, Pin, Mignotte, Bathélémy-Dubois, Caux, Lebecque, Blay: Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer. in BMC cancer 2011 (PubMed)
    Show all 4 Pubmed References

  6. Human Monoclonal CCL20 Primary Antibody für IHC (p) - ABIN786801 : Harada, Shimoda, Ikeda, Chiba, Hsu, Sato, Kobayashi, Ren, Ohta, Kasashima, Kawashima, Nakanuma: Significance of periductal Langerhans cells and biliary epithelial cell-derived macrophage inflammatory protein-3α in the pathogenesis of primary biliary cirrhosis. in Liver international : official journal of the International Association for the Study of the Liver 2011 (PubMed)
    Show all 4 Pubmed References

  7. Human Monoclonal CCL20 Primary Antibody für IHC (p) - ABIN786799 : Homey, Dieu-Nosjean, Wiesenborn, Massacrier, Pin, Oldham, Catron, Buchanan, Müller, deWaal Malefyt, Deng, Orozco, Ruzicka, Lehmann, Lebecque, Caux, Zlotnik: Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. in Journal of immunology (Baltimore, Md. : 1950) 2000 (PubMed)
    Show all 4 Pubmed References

  8. Human Monoclonal CCL20 Primary Antibody für ELISA (Detection), Func - ABIN786797 : Debeer, Le Luduec, Kaiserlian, Laurent, Nicolas, Dubois, Kanitakis: Comparative histology and immunohistochemistry of porcine versus human skin. in European journal of dermatology : EJD 2013 (PubMed)
    Show all 3 Pubmed References

  9. Human Monoclonal CCL20 Primary Antibody für ELISA (Capture), Func - ABIN786798 : Li, Estes, Schlievert, Duan, Brosnahan, Southern, Reilly, Peterson, Schultz-Darken, Brunner, Nephew, Pambuccian, Lifson, Carlis, Haase: Glycerol monolaurate prevents mucosal SIV transmission. in Nature 2009 (PubMed)
    Show all 2 Pubmed References

  10. Mouse (Murine) Polyclonal CCL20 Primary Antibody für ELISA, WB - ABIN1043828 : Harper, Guo, Rizzo, Lillis, Kurtz, Skorcheva, Purdy, Fitch, Iordanov, Blauvelt: Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. in The Journal of investigative dermatology 2009 (PubMed)

Weitere Antikörper gegen CCL20 Interaktionspartner

Rhesus Monkey Chemokine (C-C Motif) Ligand 20 (CCL20) Interaktionspartner

  1. Hypoxia is a transcriptional inducer of CCL20 in human mononuclear phagocytes.

Human Chemokine (C-C Motif) Ligand 20 (CCL20) Interaktionspartner

  1. CCL20, which is regulated by HuR and secreted into the bone microenvironment, enhances the metastatic ability and bone metastasis of breast cancer cells by stimulating cancer cells and osteoblastic cells in both autocrine and paracrine manners.

  2. CCl20 and CXCL13 synergistically increased B-cell migration form peripheral blood of rheumatoid arthritis patients.

  3. CCL20 role in glioblastoma.CCL20 expression in astrocytes during hypoxia.CCL20 up-regulates HIF-1alpha through NF-kappaB activation.

  4. S1P induced the expression of some asthma-related genes, such as ADRB2, PTGER4, and CCL20, in bronchial epithelial cells. The knock-down of SIPR3 suppressed the expression of S1P-inducing CCL20.

  5. CCL20 was upregulated in giant cell tumor of bone patients and correlated with tumor progression and poor prognosis. CCL20 recruited mononuclear cells and induced osteoclastogenesis by over-activating the AKT and NF-kappa B signaling pathways.

  6. CCL20 may play an important role in the pathogenesis of MS. Both allelic variation of (rs6749704) within CCL20 gene and (rs763780) within IL-17F gene can be considered risk factor for development of MS in Egyptian patients.

  7. These results provide evidence that necrotic cells induce the expression of CCL2/MCP-1 and CCL20/MIP-3alpha in glioblastoma cells through activation of NF-kappaB and AP-1 and facilitate the infiltration of microglia into tumor tissues.

  8. CCN1 stimulates CCL20 production in vitro and in vivo, and thus supports the notion that overexpressed CCN1 in hyperproliferating keratinocyte is functionally involved in the recruitment of inflammatory cells to skin lesions affected by psoriasis.

  9. Results demonstrated that F. nucleatum ssp. animalis and dysregulated CCL20 protein expression are important factors associated with human colorectal cancer progression.

  10. There was underexpression of the majority of genes after sunitinib treatment. The lower expression levels of IGFBP1, CCL20, CXCL6 and FGB were confirmed by qRT-PCR in all cases. The downregulation of gene expression leads us to search for methylation as a mechanism of action of the tyrosine kinase inhibitors

  11. CCL20 contributed to invasion and epithelial-mesenchymal transition of RANK over-expressed endometrial cancer cells

  12. High expression of CCL20 is associated with cutaneous T-cell lymphoma.

  13. These results showed that the higher levels of CXCL10, CCL20 and CCL22 were associated with ischemic heart disease. The serum levels of chemokines may influence by the certain traditional risk factors of IHD and some studied SNPs, but did not influence by treatment and gender of patients.

  14. The strongest OR was for CXCL8 (interleukin-8) in serum (96.8, 95% CI: 11.9-790.2). Of these 15 markers, 6 were also significantly elevated in serum from Chile (CCL20, C-reactive protein, CXCL8, CXCL10, resistin, serum amyloid A).

  15. mutually exclusive transcriptional regulation by AP-1 (cjun/cfos) and non-canonical NF-kappaB (RelB/p52) downstream of MEK-ERK and NIK-IKK-alpha-NF-kappaB2 (p100) phosphorylation, respectively was responsible for persistent Ccl20 expression in the colonic cells.

  16. CCR6(-) regulatory T cells blunt the restoration of gut Th17 cells along the CCR6-CCL20 axis in treated HIV-1-infected patients.

  17. CCL20 provoked a 2.5-fold increase of cell migration and invasion in human cancerous breast epithelial cells ; CCL20 also enhanced MMP- 2 and MMP-9 mRNAs/protein expression and activities.

  18. A gut-specific endogenously produced mediator with the capacity to modulate the IL-17/Th17 signaling response.

  19. results provide a potential explanation for involvement of the CCL20-CCR6 system in the trafficking of IL-17-producing cells to degenerated IVD tissues

  20. MFSD2B, CCL20 and STAT1, or STARD7 and ZNF512 genes may be risk or protect factors in prognosis of ADC; HTR2B, DPP4, and TGFBRAP1 genes may be risk factors in prognosis of SQC.

Mouse (Murine) Chemokine (C-C Motif) Ligand 20 (CCL20) Interaktionspartner

  1. Study provides evidence that CCL20 expression and its mRNA level are regulated by TDAG8.

  2. Obesity-induced IL-6 shifts macrophage polarization towards tumor-promoting macrophages that produce the CCL-20 in the colitis-associated colorectal cancer (CAC) microenvironment. CCL-20 promotes CAC progression by recruiting CCR6-expressing B-cells and gammadelta T cells via chemotaxis.

  3. Blocking or knockdown CCN1 expression ameliorated skin inflammation and reduced the expression of CCL20 in both imiquimod and IL-23-induced psoriasis-like mouse models.

  4. these data indicate that CCL20/CCR6 signaling may play an important role in regulating bone mass accrual, potentially by modulating osteoblast maturation, survival, and the recruitment of osteoblast-supporting cells.

  5. We crossed Ptf1a(Cre/+) ;Kras(G12D/+) mice with JNK1(-/-) mice to generate Ptf1a(Cre/+) ;Kras(G12D/+) ;JNK1(-/-) (Kras;JNK1(-/-) ) mice. Tumor weight was significantly lower in Kras;JNK1(-/-) mice than in Kras;JNK1(+/-) mice, whereas histopathological features were similar.we concluded that inhibition of activated JNK in pancreatic tumor stroma could be a potential therapeutic target to increase Ccl20 secretion

  6. mutually exclusive transcriptional regulation by AP-1 (cjun/cfos) and non-canonical NF-kappaB (RelB/p52) downstream of MEK-ERK and NIK-IKK-alpha-NF-kappaB2 (p100) phosphorylation, respectively was responsible for persistent Ccl20 expression in the colonic cells.

  7. Taken together, these data show that, in adipose tissues, IL-17A contributes to exacerbating insulin resistance-enhancing IL-6 production and promotes the infiltration of Th17 cells in cooperation with TNFalpha; these findings represent a novel hypothesis for the association between IL-17A-producing cells and type 2 diabetes.

  8. Data (including data from studies in knockout/mutant mice) suggest that expression of Ahr (aryl-hydrocarbon receptor) and its translocation into nucleus are necessary for Ahr ligand-mediated synergistic induction of Ccl20; here, TCDD is Ahr ligand.

  9. alpha-hemolytic streptococcus may exacerbate kidney damage in IgA nephropathy through CCL20 response to the effect of Th17 cells.

  10. Acquired mtDNA mutations may promote tumorigenic phenotypes through up-regulation of chemokine CCL20.

  11. Overexpression of CCL20 in human proximal tubular cells is inhibited by blockade of KCa3.1 under diabetic conditions through inhibition of the NF-kappaB pathway.

  12. Our data indicate that estradiol is important in regulating the effects of keratinocyte growth factor on mouse uterine epithelial cell secretion of CCL20 and CXCL1.

  13. CCL20 blockage lead to a diminished cerebral immune response in experimental pneumococcal meningitis.

  14. This study suggests that CCL20/IL-15 can induce a strong antitumor immune response in tumor tissues and it is a suitable candidate for cancer immunotherapy.

  15. Estrogen receptors alpha regulates CCL20/CXCL1 secretion in the female reproductive tract.

  16. Cardiac fibroblasts could recruit Th17 cells infiltration into myocardium by secreting CCL20 in acute viral myocarditis.

  17. Data indicate that a CCR6/CCL20 chemokine loop instructed rapid increase of B cells in the spleen in response to systemic administration of Nod1 agonists in a TNF-alpha-dependent manner.

  18. Neutralization of CCL20 before induction of sepsis increased mortality during sepsis accompanied with increasing epithelial apoptosis in the jejunum and augmenting serum TNF-alpha.

  19. CXCR3 promotes recruitment of Th17 cells from the blood into the liver in both human and murine liver injury. Their subsequent positioning near bile ducts is dependent on CCR6 and cholangiocyte-secreted CCL20.

  20. Findings suggest that TNF-alpha is essential in the induction of autoimmune hepatitis (AIH) through upregulation of hepatic CCL20 expression, which allows migration of dysregulated splenic T cells.

CCL20 Antigen-Profil

Protein Überblick

chemokine upregulated in ischemic brain tissue

Genbezeichner und Symbole assoziert mit CCL20

  • C-C motif chemokine ligand 20 (CCL20) Antikörper
  • chemokine (C-C motif) ligand 20b (ccl20b) Antikörper
  • chemokine (C-C motif) ligand 20 (Ccl20) Antikörper
  • C-C motif chemokine ligand 20 (Ccl20) Antikörper
  • CCL20 Antikörper
  • CKb4 Antikörper
  • exodus-1 Antikörper
  • LARC Antikörper
  • MIP-3-alpha Antikörper
  • MIP-3A Antikörper
  • MIP-3ALPHA Antikörper
  • MIP-3[a] Antikörper
  • MIP3A Antikörper
  • Scya20 Antikörper
  • si:dkey-150o13.1 Antikörper
  • ST38 Antikörper

Bezeichner auf Proteinebene für CCL20

C-C motif chemokine 20 , maacrophage inflammatory protein 3alpha , CC chemokine ligand 20 , chemokine (C-C motif) ligand 20 , chemokine CCL20/MIP-3ALPHA , chemokine CCL-C24a , CC chemokine LARC , beta chemokine exodus-1 , liver and activation-regulated chemokine , macrophage inflammatory protein 3 alpha , small inducible cytokine subfamily A (Cys-Cys), member 20 , small-inducible cytokine A20 , CC chemokine ST38 , MIP-3-alpha , beta-chemokine exodus-1 , small inducible cytokine subfamily A20

GENE ID SPEZIES
395082 Gallus gallus
448790 Canis lupus familiaris
459991 Pan troglodytes
553951 Sus scrofa
574182 Macaca mulatta
563152 Danio rerio
6364 Homo sapiens
20297 Mus musculus
29538 Rattus norvegicus
281666 Bos taurus
Ausgewählte Anbieter für anti-CCL20 (CCL20) Antikörper
Haben Sie etwas anderes gesucht?